Join to View Full Profile
2050 Kenny RdTower 10th FloorColumbus, OH 43221
Phone+1 614-293-8629
Fax+1 614-293-3112
Dr. Konda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2012 - 2015
University of Miami Hospital and Clinics/Holy Cross HospitalResidency, Internal Medicine, 2009 - 2012
Osmania Medical College NTR UHSClass of 2007
Certifications & Licensure
OH State Medical License 2015 - 2026
FL State Medical License 2009 - 2013
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Clinical Trials
- Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer Start of enrollment: 2020 Feb 10
Publications & Presentations
PubMed
- Phase 2 Study of Cabozantinib (XL184) with Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas (ETCTN10315).Adel Mandl, Ruizhe Chen, Satya Das, Jonathan R Strosberg, Anup Kasi
The Oncologist. 2026-04-10 - Approach and Challenges for Patients With Advanced Radioiodine-Refractory Differentiated Thyroid Cancer.Dipen C Patel, Irina Azaryan, Bhavana Konda
Endocrine Practice. 2026-02-01 - Appendiceal Neuroendocrine Tumors: Prognostic Role of Mesoappendiceal Invasion and Implications for Recommending Right Hemicolectomy versus Simple Appendectomy.Diamantis I Tsilimigras, Pamela Lu, Susan Tsai, Timothy M Pawlik, Bhavana Konda
Annals of Surgical Oncology. 2025-10-01
Journal Articles
- Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine TumorsNeil Saunders, David Strosberg, Jill Onesti, Carl R Schmidt, Manisha Shah, Mary Dillhoff, Lawrence A Shirley, Bhavana Konda, Annals of Surgical Oncology
Press Mentions
New Alliance Launches Clinical Trials of Targeted Therapies for Rare Adrenal CancersOctober 23rd, 2025- Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024
- Alliance Commemorates Adolescent and Young Adult Cancer Awareness WeekApril 7th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
